The Use of Breath Volatile Organic Compounds in Early Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis
Condition(s):Cystic FibrosisLast Updated:July 13, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Cystic FibrosisLast Updated:July 13, 2023Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:April 10, 2019Completed
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:December 19, 2020Terminated
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:September 7, 2023Recruiting
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:April 30, 2021Unknown status
Condition(s):COPDLast Updated:October 25, 2011Completed
Condition(s):Smoking; Airway ObstructionLast Updated:February 2, 2012Unknown status
Condition(s):Chronic Obstructive Pulmonary Disease (COPD); Decompensated COPD With (Acute) ExacerbationLast Updated:September 17, 2012Completed
Condition(s):Asthma in ChildrenLast Updated:May 9, 2017Unknown status
Condition(s):Post Extubation DysphagiaLast Updated:August 15, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.